EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC-ND 4.0

Utility of Fecal Elastase‐1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review

Senthilkumar Sankararaman iD, Sara Hendrix iD, Mandy Neudecker, Drucy Borowitz iD

Pediatric Pulmonology · 2026-05 · 61 (5)

DOI: 10.1002/ppul.71649 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Pediatric Pulmonology, online erschienen am 05.05.2026. Verfasst von Senthilkumar Sankararaman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Children's Hospital, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Feces, Exocrine Pancreatic Insufficiency, Pancreatic Elastase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In people with cystic fibrosis (pwCF), identification of exocrine pancreatic insufficiency (EPI) is essential to prevent steatorrhea and, if not managed actively, can lead to catastrophic consequences. Fecal elastase‐1 (FE‐1) is a widely used test to screen for EPI in cystic fibrosis (CF). Once thought permanent, some patients with EPI on CF transmembrane conductance regulator (CFTR)‐directed therapies (modulators) have been noted to show improvement in EPI. Here, we evaluated the utility of FE‐1 in pwCF. Methodology We performed a scoping review and searched several databases for the terms/concepts of “cystic fibrosis” and “fecal elastase‐1” and their synonyms. The search period was from 1‐1‐2003 to 7‐31‐2025. We included all age groups and used a web‐based platform for compiling and sorting out the articles.

Results

We combined the eligible studies to synthesize information on four questions: Utilization of FE‐1 in CF (when to screen for EPI, how often to screen); Comparison of diagnostic accuracy of FE‐1 versus other tests; Definition of ideal cut‐off for FE‐1 in evaluating EPI in CF; Utilization of FE‐1 in pwCF managed on CFTR‐directed therapies.

Conclusion

All pwCF should have EPI evaluated at diagnosis. Among various tests, FE‐1 is the most commonly utilized test for screening EPI. A value of < 200 μg/g of stool is consistent with EPI and is highly sensitive for EPI diagnosis. A value of < 100 μg/g is highly specific for severe EPI. Repeating FE‐1 should be considered in the current era of modulators, especially with a change in clinical status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisFecesExocrine Pancreatic InsufficiencyPancreatic ElastaseHumans

Stichwörter der Autor:innen

CFFE‐1PE‐1cystic fibrosisexocrine pancreatic insufficiencyfecal elastase‐1pancreatic elastase‐1

Substanzen

Pancreatic Elastase

Autor:innen und Institutionen

  • Cleveland Clinic Children's Hospital, Cleveland, Ohio, USA.
  • Medical University of South Carolina, Charleston, South Carolina, USA.
  • UH Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
  • Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.

ORCID-Profile: Senthilkumar Sankararaman, Sara Hendrix, Drucy Borowitz

Zitieren

APA

Sankararaman, S., Hendrix, S., Neudecker, M., & Borowitz, D. (2026). Utility of Fecal Elastase‐1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review. Pediatric Pulmonology, 61(5). https://doi.org/10.1002/ppul.71649

Vancouver

Sankararaman S, Hendrix S, Neudecker M, Borowitz D. Utility of Fecal Elastase‐1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review. Pediatric Pulmonology. 2026;61(5). doi:10.1002/ppul.71649

BibTeX
@article{Sankararaman2026,
  author = {Sankararaman, Senthilkumar and Hendrix, Sara and Neudecker, Mandy and Borowitz, Drucy},
  title = {Utility of Fecal Elastase‐1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review},
  journal = {Pediatric Pulmonology},
  year = {2026},
  volume = {61},
  number = {5},
  doi = {10.1002/ppul.71649}
}
Kostenlos starten →